InnaMed on Republic

Using smart, at-home blood testing technology to enable personalized medicine.

CLOSED

see other companies in category:

visit:
InnaMed Website

minimum raise

$50,000

maximum raise

$1,070,000

start date

04/30/2019

stop date

07/31/2019

security type

SAFE

investment minimum

$60

raised to date

$1,070,000

reporting date

CLOSED

number of investors

2

percent of minimum raised

2,140%

percent of maximum raised

100%

likelihood of reaching max

Likely to Reach Max

dollars per day to reach max

$0

dollars per day committed

$11,630

dollars per day - category-

$2,681

dollars per day committed - all companies

$1,012
More SEC Filing Data on InnaMed from Crowdfilings.com

InnaMed, with a valuation cap of $12 million, is raising crowdfunding on Republic. The company is developing an at-home testing device called TeleLab. The device can be filled with several disease-specific test cartridges and helps to monitor the patients remotely. InnaMed is using modern blood collection techniques, cloud computing, and its patented electrochemical blood analysis technology to provide lab-level testing at home. The company was founded by Eshwar Inapuri, Alan Jernigan, and Anup Singh in May 2016, and has already developed two prototypes. The proceeds of the crowdfunding round, with a minimum target of $50,000 and a maximum target of $1,070,000, will be used for clinical validation and beta testing of the device. InnaMed already has $400,000 in contracts with U.S. government agencies and a top global pharma company.